Sequent Scientific acquires 24.78% stake in Alivira

01 Apr 2015 Evaluate

Sequent Scientific has acquired 7,400,000 equity shares of Alivira Animal Health (Alivira) representing 24.78% of paid up equity capital from Shasun Pharmaceuticals. Post this acquisition, the company now holds 91.92% of paid up equity capital of Alivira.

Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. Sequent is the world's largest producer of Anthelmintics and by far the strongest player in the Veterinary API business.



Viyash Scientific Share Price

198.55 4.45 (2.29%)
22-Jan-2026 10:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1642.00
Dr. Reddys Lab 1214.70
Cipla 1380.00
Zydus Lifesciences 884.95
Lupin 2184.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×